Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1628
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18700884 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE COMPRISING LYSOPHOSPHOLIPID | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18710141 | METHOD OF MAKING BUPRENORPHINE AND PRECURSOR COMPOUNDS THEREOF | Non-Final OA | Arevipharma GmbH |
| 18682227 | USE OF ENSARTINIB OR SALT THEREOF IN TREATMENT OF DISEASE CARRYING MET 14 EXON SKIPPING MUTATION | Non-Final OA | BETTA PHARMACEUTICALS CO., LTD |
| 18523219 | Use of [1,2,4] Triazolo [4,3-B] Pyridazine Derivative For Preventing and Treating Senescence and Senescence-Related Diseases | Non-Final OA | The Eighth Affiliated Hospital, Sun Yat-Sen University |
| 18517497 | BRIARANE COMPOUNDS AND THEIR USE | Non-Final OA | National Museum of Marine Biology and Aquarium |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy